Safety and Efficacy of Canagliflozin in Patients With Metastatic High Microsatellite Instability (MSI-H) Colorectal Cancer

NCT07076823 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer
SGLT-2 Inhibitor

Interventions

DRUG: Canagliflozin

Sponsor

West China Hospital